BRPI0408249A - vacinas bovinas com adjuvante - Google Patents

vacinas bovinas com adjuvante

Info

Publication number
BRPI0408249A
BRPI0408249A BRPI0408249-4A BRPI0408249A BRPI0408249A BR PI0408249 A BRPI0408249 A BR PI0408249A BR PI0408249 A BRPI0408249 A BR PI0408249A BR PI0408249 A BRPI0408249 A BR PI0408249A
Authority
BR
Brazil
Prior art keywords
coli
adjuvanted
shelter
adjuvant
bovine vaccines
Prior art date
Application number
BRPI0408249-4A
Other languages
English (en)
Inventor
Hsien-Jue Chu
Wumin Li
Original Assignee
Wyeth Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wyeth Corp filed Critical Wyeth Corp
Publication of BRPI0408249A publication Critical patent/BRPI0408249A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/025—Enterobacteriales, e.g. Enterobacter
    • A61K39/0258—Escherichia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A61K2039/552—Veterinary vaccine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55505—Inorganic adjuvants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55566—Emulsions, e.g. Freund's adjuvant, MF59
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Mycology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Microbiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Fodder In General (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

"VACINAS BOVINAS COM ADJUVANTE". A presente invenção refere-se a uma composição de vacina segura e eficaz contra abrigo de E. coli O157:H7. Um componente imunogenicamente ativo, E. coli O157:H7, um adjuvante, tal como um óleo metabolizável, e um veículo farmaceuticamente aceitável são formulados em uma vacina para imunização. A invenção também proporciona um método para a prevenção ou alívio de abrigo de E coli O157:H7.
BRPI0408249-4A 2003-03-12 2004-03-05 vacinas bovinas com adjuvante BRPI0408249A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US45418203P 2003-03-12 2003-03-12
PCT/US2004/006941 WO2004080400A2 (en) 2003-03-12 2004-03-05 Adjuvanted bovine vaccines

Publications (1)

Publication Number Publication Date
BRPI0408249A true BRPI0408249A (pt) 2006-03-01

Family

ID=32990880

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0408249-4A BRPI0408249A (pt) 2003-03-12 2004-03-05 vacinas bovinas com adjuvante

Country Status (12)

Country Link
US (1) US20040180060A1 (pt)
EP (1) EP1601375A2 (pt)
JP (1) JP2006519880A (pt)
AR (1) AR043539A1 (pt)
AU (2) AU2004220543A1 (pt)
BR (1) BRPI0408249A (pt)
CA (1) CA2517498A1 (pt)
CO (1) CO5660272A2 (pt)
MX (1) MXPA05009447A (pt)
NZ (1) NZ542253A (pt)
TW (1) TWI350174B (pt)
WO (1) WO2004080400A2 (pt)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2005042746A1 (en) 2003-10-31 2005-05-12 The University Of British Columbia Bacterial virulence factors and uses thereof
UA98812C2 (ru) 2007-11-06 2012-06-25 Вайет Ллк Авирулентная активированная живая вакцина mycoplasma hyopneumoniae
EP2485725A2 (en) * 2009-10-07 2012-08-15 Wyeth LLC Compositions comprising adjuvant, macrolide and proteinaceous antigen and methods of use thereof
EP2711013A4 (en) * 2011-05-18 2015-03-04 Ajinomoto Kk IMMUNSTIMULANDS FOR ANIMALS, FEED THEREFOR AND MANUFACTURING PROCESS THEREFOR
UA130246C2 (uk) * 2013-09-19 2025-12-31 Зоетіс Сервісіз Ллс Ад'ювант на основі олії

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0827028A (ja) * 1994-07-21 1996-01-30 Nippon Seibutsu Kagaku Kenkyusho 油性アジュバント及びアルミニウムゲルアジュバントからなる動物用ワクチン製剤
US5730989A (en) * 1995-02-16 1998-03-24 Novavax, Inc. Oral vaccine against gram negative bacterial infection
US5976580A (en) * 1995-06-07 1999-11-02 Novus International, Inc. Nutrient formulation and process for enhancing the health, livability, cumulative weight gain or feed efficiency in poultry and other animals
US5965128A (en) * 1997-08-13 1999-10-12 University Of Georgia Research Foundation Inc. Control of enterohemorrhagic E. coli 0157:H7 in cattle by probiotic bacteria and specific strains of E. coli
JP4282804B2 (ja) * 1998-12-24 2009-06-24 新日本石油株式会社 アジュバント組成物
EP1195162B1 (en) * 1999-03-03 2008-06-04 The Kitasato Institute Vaccine preparation containing fatty acid as a constituent
GB9923176D0 (en) * 1999-09-30 1999-12-01 Smithkline Beecham Biolog Novel composition
JP2001131087A (ja) * 1999-11-05 2001-05-15 Chemo Sero Therapeut Res Inst オイルアジュバントワクチン
EP1240328B1 (en) * 1999-11-29 2006-01-11 Akzo Nobel N.V. Antigenic protein lppq of mycoplasma mycoides subsp. mycoides sc., its preparation and use
US6162441A (en) * 1999-12-15 2000-12-19 Republic Of Korea (Management: Rural Development Administration) Method for the production of anti-escherichia. coli O157 : H7 antibody
AUPQ761200A0 (en) * 2000-05-19 2000-06-15 Hunter Immunology Limited Compositions and methods for treatment of mucosal infections
WO2002017961A1 (en) * 2000-08-31 2002-03-07 The Kitasato Institute Vaccine preparation containing fatty acid as component
NZ527322A (en) * 2001-01-04 2005-07-29 Univ Saskatchewan EHEC cell culture supernatant vaccine
DK1372708T3 (da) * 2001-02-13 2008-10-20 Us Gov Sec Army Vaccine til transkutan immunisering mod rejsediarre
EP1314359A1 (en) * 2001-11-21 2003-05-28 N.V. Seghers Nutrition Sciences Growth promoter composition for animals

Also Published As

Publication number Publication date
CO5660272A2 (es) 2006-07-31
JP2006519880A (ja) 2006-08-31
WO2004080400A2 (en) 2004-09-23
AU2004220543A1 (en) 2004-09-23
MXPA05009447A (es) 2005-11-23
US20040180060A1 (en) 2004-09-16
CA2517498A1 (en) 2004-09-23
TWI350174B (en) 2011-10-11
AR043539A1 (es) 2005-08-03
TW200423956A (en) 2004-11-16
AU2010202344A1 (en) 2010-07-01
WO2004080400A3 (en) 2005-03-03
NZ542253A (en) 2008-07-31
EP1601375A2 (en) 2005-12-07

Similar Documents

Publication Publication Date Title
BR0211492A (pt) Vacina para west nile
WO2006068663A3 (en) Vaccine compositions for treating coronavirus infection
WO2005116270A3 (en) Influenza virus vaccine composition and method of use
MX2010008468A (es) Acidos nucleicos de la formula (i) (nug1xmgnnv)a y derivados de los mismos como un agente/adyuvante inmunoestimulante.
ATE315404T1 (de) Influenzavirus-impfstoffzusammensetzung
EE200200507A (et) Muundatud vaktsiiniaviirus Ankara (MVA), sellega nakatatud peremeesrakk ning seda sisaldav farmatseutiline kompositsioon, MVA valmistamine ja raviotstarbeline kasutamine
WO2006065553A3 (en) Glycoconjugate vaccines containing peptidoglycan
EA200900350A1 (ru) Вакцина, содержащая адъювант в виде эмульсии "масло в воде"
EP1499191A4 (en) REGULATED ATTENUATION OF LIVE VACCINES TO ENHANCE CROSS-PROTECTIVE IMMUNOGENICITY
WO2007117303A3 (en) Combination vaccine comprising an attenuated bovine viral diarrhea virus
ES2195169T3 (es) Vacunas contra calmidias y composiciones inmunogenicas que contienen un antigeno de membrana externa y metodos para su preparacion.
MX9401225A (es) Composicion de vacuna para prevenir la infeccion con influenza en humanos y metodo para su preparacion.
BR0212556A (pt) interleucina-12 como um adjuvante de vacina veterinária
BR0011225A (pt) Agente para tratar de olhos secos, seu método e uso
WO2009129336A3 (en) Penetrating carrier, antifungal composition using the same and method for treatment of dermatophyte infections
RU2013126888A (ru) ИММУНОМОДУЛИРУЮЩИЕ КОМПОЗИЦИИ, СПОСОБЫ И СИСТЕМЫ, СОДЕРЖАЩИЕ ИММУНОГЕННЫЕ ФРАГМЕНТЫ АроВ100
WO2006062807A3 (en) Compositions with enhanced immunogenicity
BR0111834A (pt) Composições adjuvante e imunogênica, e, método para eliciar uma resposta imune a um antìgeno
WO2007002470A3 (en) Inactivated chimeric vaccines and related methods of use
DK1395283T3 (da) Heterolog beskyttelse induceret ved immunisering med Invaplex-vaccine
CR8638A (es) Vacuna agalactiae estreptococos
BRPI0408249A (pt) vacinas bovinas com adjuvante
WO2007081896A3 (en) Pharmaceutical compositions and methods to vaccinate against disseminated candidiasis and other infectious agents
DE60031243D1 (de) Impfstofformulierung gegen tuberkulose mit monoglyceriden oder fettsäuren als adjuvant
WO2001022994A3 (en) Vaccines against neisseria infection

Legal Events

Date Code Title Description
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 10A ANUIDADE.

B09B Patent application refused [chapter 9.2 patent gazette]

Free format text: INDEFIRO O PEDIDO DE ACORDO COM O(S) ARTIGO(S) 8O, 11, 13, 10 DA LPI

B09B Patent application refused [chapter 9.2 patent gazette]

Free format text: MANTIDO O INDEFERIMENTO UMA VEZ QUE NAO FOI APRESENTADO RECURSO DENTRO DO PRAZO LEGAL.